Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future.

Zhang, Zeng; Tan, Xin; Jiang, Zengxin; Wang, Hao; Yuan, Hengfeng

Zhang, Zeng; Tan, Xin; Jiang, Zengxin; Wang, Hao; Yuan, Hengfeng.

Afiliação

Zhang Z; Department of Orthopedics, Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, China.
Tan X; Department of Orthopedics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jiang Z; Department of Orthopedics, Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, China.
Wang H; Department of Orthopedics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yuan H; Department of Orthopedics, Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, China.

Front Pharmacol ; 13: 1031527, 2022.

Article em En | MEDLINE | ID: mdl-36324681

Palavras-chave

immune checkpoint inhibitor; immunotherapy; mechanism; osteosarcoma; side effects

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google